LabQMHub Editorial Team · ISO 15189:2022 Quality Management Series
Not every laboratory test produces a number. Rapid antigen tests, microbiology culture identification, blood typing, and many point-of-care tests report a category — positive or negative, reactive or nonreactive, a specific blood group — and the statistical tools built for numeric results, covered in the previous course, do not directly apply. Yet these tests carry exactly the same clinical stakes as their quantitative counterparts.
ISO 15189:2022 recognizes this distinction and expects laboratories to build a quality control approach specifically suited to qualitative and semi-quantitative methods, rather than either skipping meaningful control altogether or awkwardly forcing a numeric framework onto results that were never numeric to begin with.
Why Qualitative Tests Need a Different Control Approach
Without a numeric value, quality control for qualitative tests instead relies on positive and negative control materials with known, expected outcomes, run alongside patient testing to confirm the test system correctly distinguishes a true positive from a true negative under current conditions. A control that produces an unexpected result signals the test system — reagents, technique, or equipment — is not functioning as it should.
Semi-quantitative tests, which report a graded result such as a titer or a numeric score within a limited range, often combine elements of both approaches — control materials with expected categorical outcomes, sometimes supplemented by numeric scoring consistency checks appropriate to the specific method.
Selecting and Managing Control Materials
Control materials should be chosen to challenge the test system meaningfully — a weak positive control, for example, is often more informative than a strong positive, since it tests the method’s sensitivity closer to its actual detection limit, where genuine analytical problems are more likely to first appear.
Control material storage, handling, and expiry management follow the same disciplined principles covered in this program’s reagent management course, since a degraded control material can itself produce a false control result, masking or falsely suggesting a test system problem that does not actually exist.
Frequency and Documentation of Qualitative Control Testing
Control frequency should reflect test volume, the consequences of a missed or false result, and manufacturer recommendations — a new lot of a rapid test kit should always be verified with both positive and negative controls before patient use, in addition to routine ongoing control testing, connecting to the lot verification principles covered in this program’s reagent management course.
Documentation should record not just a pass or fail outcome, but the specific control material, lot number, and result observed, providing the traceability needed to investigate a pattern of control problems that might not be obvious from a single day’s records alone.
Special Considerations for Point-of-Care and Rapid Testing
Point-of-care tests, often performed by staff outside the core laboratory, present a particular quality control challenge: the laboratory remains responsible for oversight of testing quality, per this program’s earlier continuity and coverage discussions, even though the actual testing occurs at the bedside or in a decentralized clinical setting.
Effective oversight includes standardized training for point-of-care operators, defined control testing schedules that are actually enforced and verified, and a mechanism for the laboratory to review point-of-care quality control data centrally, rather than assuming decentralized testing sites are managing quality independently and adequately without any central visibility.
Frequently Asked Questions
Why can’t Westgard rules be applied to qualitative test results?
Westgard rules depend on numeric data distributed around a target value; qualitative results are categorical (positive/negative), so control strategy instead relies on expected outcomes for known positive and negative materials.
Is a weak positive control more useful than a strong positive control?
Often yes — a weak positive challenges the test closer to its actual detection limit, where subtle problems in sensitivity are more likely to surface than with a strongly positive sample.
Who is responsible for quality control at point-of-care testing sites?
The core laboratory retains oversight responsibility, including training standards, control schedules, and centralized review of point-of-care quality control data, even though testing occurs outside the main laboratory.
Key Takeaways
- Qualitative and semi-quantitative tests require a quality control approach built around expected categorical outcomes, not numeric statistical rules.
- Positive and negative control materials confirm the test system correctly distinguishes true results under current conditions.
- Weak positive controls often provide more meaningful information than strong positive controls, testing closer to the method’s actual detection limit.
- New lots of qualitative test kits should be verified with both positive and negative controls before patient use.
- Documentation should capture control material, lot number, and specific result, supporting investigation of patterns across multiple days.
- Point-of-care testing requires central laboratory oversight of quality control, even when testing occurs outside the core laboratory.
Conclusion
Qualitative and semi-quantitative tests are sometimes mistakenly treated as lower-stakes simply because they lack a numeric result, but a false negative infectious disease screen or a misidentified blood type carries consequences every bit as serious as a quantitative error.
ISO 15189:2022’s flexible, method-appropriate approach to quality control ensures these tests receive genuine, meaningful oversight — matched to how they actually work, rather than an ill-fitting numeric framework borrowed from quantitative testing.
Learn how external quality assessment complements internal quality control in the next course of this ISO 15189:2022 training series.
Source note: this article draws on “Quality Management in Clinical Laboratory Demystified” by Dr. Taleb Chalab Cham, ISO 15189:2022, and widely recognized clinical laboratory quality references including CLSI guidelines, CAP accreditation checklists, and WHO laboratory quality guidance.
